BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Egwuagu CE, Alhakeem SA, Mbanefo EC. Uveitis: Molecular Pathogenesis and Emerging Therapies. Front Immunol 2021;12:623725. [PMID: 33995347 DOI: 10.3389/fimmu.2021.623725] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 9.0] [Reference Citation Analysis]
Number Citing Articles
1 Wu X, Tao M, Zhu L, Zhang T, Zhang M. Pathogenesis and current therapies for non-infectious uveitis. Clin Exp Med 2022. [DOI: 10.1007/s10238-022-00954-6] [Reference Citation Analysis]
2 Zhang D, Zhang N, Wang Y, Zhang Q, Wang J, Yao J. Analysis of differentially expressed genes in individuals with noninfectious uveitis based on data in the gene expression omnibus database. Medicine 2022;101:e31082. [DOI: 10.1097/md.0000000000031082] [Reference Citation Analysis]
3 Lu S, Wang H, Zhang J. Identification of uveitis-associated functions based on the feature selection analysis of gene ontology and Kyoto Encyclopedia of Genes and Genomes pathway enrichment scores. Front Mol Neurosci 2022;15:1007352. [DOI: 10.3389/fnmol.2022.1007352] [Reference Citation Analysis]
4 Yu C, Yadav MK, Kang M, Jittayasothorn Y, Dong L, Egwuagu CE. Photoreceptor Cells Constitutively Express IL-35 and Promote Ocular Immune Privilege. IJMS 2022;23:8156. [DOI: 10.3390/ijms23158156] [Reference Citation Analysis]
5 Jin Y, Lu S, Lin Y, Mou X. The efficacy and safety of TNF inhibitor (golimumab) as salvage treatment in patients with refractory noninfectious uveitis. Inflammopharmacology 2022. [PMID: 35802282 DOI: 10.1007/s10787-022-01019-6] [Reference Citation Analysis]
6 Kingsley NB, Sandmeyer L, Bellone RR. A review of investigated risk factors for developing equine recurrent uveitis. Vet Ophthalmol 2022. [PMID: 35691017 DOI: 10.1111/vop.13002] [Reference Citation Analysis]
7 Xu H, Rao NA. Grand Challenges in Ocular Inflammatory Diseases. Front Ophthalmol 2022;2:756689. [DOI: 10.3389/fopht.2022.756689] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
8 Cao F, He YS, Xiang K, Wan CH, Liu W, Gui YC, Pan HF, Jiang ZX, Tao LM. Association between meteorological factors and hospital admissions for uveitis in Hefei, China: a time-series study. Environ Sci Pollut Res Int 2022. [PMID: 35149948 DOI: 10.1007/s11356-022-19092-3] [Reference Citation Analysis]
9 Fang G, Wang Q, Yang X, Qian Y, Zhang G, Tang B. γ-Cyclodextrin-based polypseudorotaxane hydrogels for ophthalmic delivery of flurbiprofen to treat anterior uveitis. Carbohydr Polym 2022;277:118889. [PMID: 34893291 DOI: 10.1016/j.carbpol.2021.118889] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
10 Chen YH, Lightman S, Eskandarpour M, Calder VL. Adhesion Molecule Targeted Therapy for Non-Infectious Uveitis. Int J Mol Sci 2022;23:503. [PMID: 35008929 DOI: 10.3390/ijms23010503] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
11 Stofkova A, Zloh M, Andreanska D, Fiserova I, Kubovciak J, Hejda J, Kutilek P, Murakami M. Depletion of Retinal Dopaminergic Activity in a Mouse Model of Rod Dysfunction Exacerbates Experimental Autoimmune Uveoretinitis: A Role for the Gateway Reflex. Int J Mol Sci 2021;23:453. [PMID: 35008877 DOI: 10.3390/ijms23010453] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]